AIM IMMUNOTECH INC. Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value
AIM IMMUNOTECH INC. (AIM) had Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value of $1.40 million as of 2018-09-30, per its 10-Q filed 2018-11-14.
Discontinued › Notes › Fair Value Measures and Disclosures › Fair Value Disclosures › Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation
us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue · last filed 2018-11-14
- 2018-09-30: Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value $1.40M.
- 2018-06-30: Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value $2.10M.
- 2018-03-31: Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value $971.00K.
- 2017-12-31: Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value $962.00K.
| Period end | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value |
|---|---|
| 2018-09-30 | $1.40M 10-Q · filed 2018-11-14 |
| 2018-06-30 | $2.10M 10-Q · filed 2018-08-14 |
| 2018-03-31 | $971.00K 10-Q · filed 2018-05-15 |
| 2017-12-31 | $962.00K 10-Q · filed 2018-11-14 |
| 2017-09-30 | $1.02M 10-Q · filed 2017-11-14 |
| 2017-06-30 | $2.52M 10-Q · filed 2017-08-14 |
| 2017-03-31 | $1.28M 10-Q · filed 2017-05-15 |
| 2016-12-31 | $940.00K 10-K · filed 2018-03-30 |
| 2016-09-30 | $2.51M 10-Q · filed 2016-11-14 |
| 2013-12-31 | $14.00K 10-K · filed 2017-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Silexion Therapeutics Corp (SLXN) | $0.001B |